Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is one of the most lethal subtypes of breast cancer (BC), and it accounts for approximately 10%–20% of all invasive BCs diagnosed worldwide. The survival rate of TNBC in stages III and IV is very low, and a large number of patients are diagnosed in these stages....

Descripción completa

Detalles Bibliográficos
Autores principales: Alam, Md Shahin, Sultana, Adiba, Wang, Guanghui, Haque Mollah, Md Nurul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768339/
https://www.ncbi.nlm.nih.gov/pubmed/36567949
http://dx.doi.org/10.3389/fmolb.2022.1049741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768339/
https://www.ncbi.nlm.nih.gov/pubmed/36567949
http://dx.doi.org/10.3389/fmolb.2022.1049741

Ejemplares similares